NDC 10019-008 – Transderm Scop
Scopolamine 1 mg/3d · Patch, Extended Release · Transdermal
Product NDC10019-008
Product details
- Brand name
- Transderm Scop
- Generic name
- Scopolamine
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- NDA · NDA017874
- Marketed since
- December 1, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic
Active ingredients
- Scopolamine 1 mg/3d
Uses, dosage, side effects and warnings for Transderm Scop →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 10019-008-01 | 1 PATCH in 1 POUCH (10019-008-01) / 3 d in 1 PATCH | Jun 10, 2026 |
| 10019-008-04 | 4 POUCH in 1 BOX (10019-008-04) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH | Jun 10, 2025 |
| 10019-008-10 | 10 POUCH in 1 BOX (10019-008-10) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH | Jun 10, 2025 |
| 10019-008-24 | 24 POUCH in 1 BOX (10019-008-24) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH | Jun 10, 2025 |
Recalls mentioning this NDC
- D-1083-2022 Jun 15, 2022 · Class II
cGMP deviations: Temperature abuse